An Observational Study of Hemoglobin Stability in Chronic Kidney Disease Patients on Dialysis Treated With Mircera (Methoxy Polyethylene Glycol-epoetin Beta)
NCT ID: NCT01974271
Last Updated: 2016-11-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
661 participants
OBSERVATIONAL
2014-01-31
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic kidney disease patients on hemodialysis or hemodiafiltration for at least 3 months
* Previously treated with an erythropoietin stimulating agent (ESA)
* Patient for whom the investigator decided to initiate treatment with Mircera for medical reasons
* Last hemoglobin level before initiation of Mircera within the range of 10-12 g/dL
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aix-en-Provence, , France
Ajaccio, , France
Annonay, , France
Arras, , France
Auch, , France
Aurillac, , France
Beauvais, , France
Beauvais, , France
Bois-Bernard, , France
Bordeaux, , France
Bourg-en-Bresse, , France
Bourgoin, , France
Brest, , France
Chamalières, , France
Chaumont, , France
Clermont-Ferrand, , France
Clermont-Ferrand, , France
Colmar, , France
Condom, , France
Dijon, , France
Dourlers, , France
Épinal, , France
Fleurance, , France
Fourmies, , France
Gap, , France
Gradignan, , France
Haguenau, , France
La Roche-sur-Yon, , France
La Tronche, , France
Le Mans, , France
Le Puy-en-Velay, , France
Libourne, , France
Lille, , France
Maubeuge, , France
Meaux, , France
Mirande, , France
Montereau, , France
Nantes, , France
Nantes, , France
Neuilly-sur-Seine, , France
Nîmes, , France
Nogaro, , France
Noyal-Pontivy, , France
Olivet, , France
Orléans, , France
Paris, , France
Paris, , France
Paris, , France
Paris, , France
Pessac, , France
Poitiers, , France
Quimper, , France
Quincy-sous-Sénart, , France
Rambouillet, , France
Rennes, , France
Rezé, , France
Roubaix, , France
Rouen, , France
Saint-Brieuc, , France
Saint-Laurent-du-Var, , France
Saint-Lô, , France
Saint-Marcel, , France
Saint-Nazaire, , France
Saint-Ouen, , France
Saint-Priest-en-Jarez, , France
Salouël, , France
Saran, , France
Stains, , France
Strasbourg, , France
Toulouse, , France
Tourcoing, , France
Valenciennes, , France
Vandœuvre-lès-Nancy, , France
Vesoul, , France
Villefranche-de-Rouergue, , France
Yssingeaux, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML28980
Identifier Type: -
Identifier Source: org_study_id